GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.234
+0.028 (13.82%)
At close: Dec 20, 2024, 4:00 PM
0.230
-0.004 (-1.67%)
After-hours: Dec 20, 2024, 7:51 PM EST
GlycoMimetics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -39.74 | -36.9 | -46.69 | -63.43 | -51.03 | -57.89 | |
| Depreciation & Amortization | 0.06 | 0.15 | 0.21 | 0.26 | 0.27 | 0.28 | |
| Loss (Gain) From Sale of Assets | 0.09 | 0.01 | 0 | 0 | - | - | |
| Stock-Based Compensation | 4.56 | 3.56 | 3.86 | 6.09 | 6.9 | 6.22 | |
| Other Operating Activities | 0.59 | 0.86 | 0.83 | 0.75 | 0.68 | 0.62 | |
| Change in Accounts Payable | 0.25 | -0.1 | -1.14 | 0.02 | 0.65 | -1.23 | |
| Change in Other Net Operating Assets | -1.18 | -2.46 | -3.52 | -1.18 | 3.28 | 0.02 | |
| Operating Cash Flow | -35.01 | -34.88 | -46.46 | -57.49 | -39.24 | -51.98 | |
| Capital Expenditures | -0.01 | -0.02 | -0.08 | -0.01 | -0.07 | -0.14 | |
| Investing Cash Flow | -0.01 | -0.02 | -0.08 | -0.01 | -0.07 | -0.14 | |
| Issuance of Common Stock | 0.01 | 28.82 | 4.16 | 10.72 | 18.14 | 0.41 | |
| Financing Cash Flow | 0.01 | 28.82 | 4.16 | 10.72 | 18.14 | 0.41 | |
| Net Cash Flow | -35.02 | -6.08 | -42.38 | -46.78 | -21.17 | -51.72 | |
| Free Cash Flow | -35.02 | -34.9 | -46.54 | -57.5 | -39.31 | -52.13 | |
| Free Cash Flow Margin | -350223.62% | -349012.97% | -62055.57% | -4958.28% | -386.80% | - | |
| Free Cash Flow Per Share | -0.54 | -0.55 | -0.89 | -1.12 | -0.86 | -1.21 | |
| Levered Free Cash Flow | -18.62 | -21.88 | -30.82 | -33.32 | -20.62 | -32.61 | |
| Unlevered Free Cash Flow | -18.62 | -21.88 | -30.82 | -33.32 | -20.62 | -32.61 | |
| Change in Net Working Capital | 0.23 | 1.02 | 5.17 | 0 | -4.47 | 0.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.